VSV-EBOPLUS brings together 11 leading international, both clinical and high-tech, vaccine research institutes and non-profit organization from 5 EU countries, Brazil and clinical sites in USA and Africa. The partners provide state-of-the art facilities and clinical vaccination research infrastructures that will work together to facilitate Ebola vaccine development.

The VSV-EBOPLUS project is coordinated by the Sclavo Vaccines Association (www.sclavo.org), a non-profit organization devoted to support research and development of human vaccines.